Arecor Therapeutics (LON:AREC) Sets New 12-Month Low at $90.00

Shares of Arecor Therapeutics plc (LON:ARECGet Free Report) hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 90 ($1.17) and last traded at GBX 93 ($1.21), with a volume of 8991 shares. The stock had previously closed at GBX 94.50 ($1.23).

Arecor Therapeutics Stock Down 1.6 %

The firm has a market cap of £28.49 million, a P/E ratio of -506.65 and a beta of -0.21. The company has a debt-to-equity ratio of 3.55, a quick ratio of 6.24 and a current ratio of 2.17. The firm’s fifty day moving average is GBX 131.63 and its 200 day moving average is GBX 143.22.

About Arecor Therapeutics

(Get Free Report)

Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.

Featured Stories

Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.